demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID 19 hospitalized
COVID-19 severe or critically
Immunostimulants drugs
convalescent plasma treatment CAPSID PICP19 ... Duan AlQahtani Ray Li Joyner Sean REMAP-CAP ... Rasheed RECOVER Bihariesingh-Sanchit ... Hegerova Pouladzadeh CP-COVID-19 O’Donnell ILBS-COVID-02 ... PlasmAr Sekine ...
immunoglobulin therapy Raman Tabarsi Gharebaghi
interferon
IFN beta-1a Davoudi-Monfared Kalil ... Darazam ...
IFN beta-1b Darazam ... Rahmani
neutralizing antibody
equine polyclonal antibodies INM005 Lopardo

7 studies excluded by filtering options 2

5405 Ahn, 2020 200excludedrisk of bias not avaialble
5408 Shen, 2020 200excludedrisk of bias not avaialble
5409 Ye, 2020 200excludedrisk of bias not avaialble
5410 Zhang, 2020 200excludedrisk of bias not avaialble
5411 Zhang, 2020 200excludedrisk of bias not avaialble
5569 Dai W, 2020 2134excludednot a RCThigh risk of bias
10178 Bargay-Lleonart, 2022 210excludedrisk of bias not avaialble